Accessibility Menu
Cochlear logo

Cochlear

(OTC) CHEOY

Current Price$41.90
Market Cap$5.47B
Since IPO (2009)+87%
5 Year-52%
1 Year-57%
1 Month+20%

Cochlear Financials at a Glance

Market Cap

$5.47B

Revenue (TTM)

A$4.65B

Net Income (TTM)

A$712.84M

EPS (TTM)

$1.70

P/E Ratio

24.62

Dividend

$1.45

Beta (Volatility)

0.69 (Low)

Price

$41.90

Volume

36,009

Open

$42.02

Previous Close

$41.90

Daily Range

$41.68 - $42.14

52-Week Range

$31.82 - $105.60

Estimated Earnings Date

Feb 11, 2026

CHEOY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cochlear

Industry

Healthcare Equipment and Supplies

Employees

5,500

CEO

Diggory William Howitt, MBA

Headquarters

Sydney, NSW 2109, AU

CHEOY Financials

Key Financial Metrics (TTM)

Gross Margin

73.03%

Operating Margin

19.98%

Net Income Margin

14.62%

Return on Equity

17.76%

Return on Capital

18.58%

Return on Assets

12.36%

Earnings Yield

4.06%

Dividend Yield

3.46%

Payout Ratio

81.47%

Stock Overview

Market Cap

$5.47B

Shares Outstanding

130.60M

Volume

36.01K

Avg. Volume

87.15K

Financials (TTM)

Gross Profit

A$3.44B

Operating Income

A$962.65M

EBITDA

A$1.13B

Operating Cash Flow

A$603.59M

Capital Expenditure

-A$129.69M

Free Cash Flow

A$473.90M

Cash & ST Invst.

A$186.91M

Total Debt

A$427.38M

Cochlear Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$1.15B

+3.7%

Gross Profit

A$841.08M

+1.6%

Gross Margin

72.86%

N/A

Market Cap

$5.47B

N/A

Market Cap/Employee

$1.10M

N/A

Employees

4,996

N/A

Net Income

A$158.54M

-17.2%

EBITDA

A$267.40M

-11.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$186.91M

-61.5%

Total Debt

A$427.38M

+106.8%

Accounts Receivable

A$564.04M

+48.7%

Inventory

A$565.54M

+75.9%

Long Term Debt

A$385.22M

+130.8%

Short Term Debt

A$42.16M

+5.9%

Return on Assets

12.36%

N/A

Return on Invested Capital

21.12%

N/A

Free Cash Flow

A$106.80M

-6.6%

Operating Cash Flow

A$134.29M

-14.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALBBYAlibaba Health Information Technology Limited
$8.00+0.00%
WILLFDemant A/S
$40.23+0.00%
WILYYDemant A/S
$20.66+0.00%
CHJTFCSPC Pharmaceutical Group Limited
$0.98+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
INTCIntel
$120.35-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%

Questions About CHEOY

What is the current price of Cochlear?

Cochlear is trading at $41.90 per share.

What is the 52-week range for Cochlear?

Over the past 52 weeks, Cochlear has traded between $31.82 and $105.60.

How much debt does Cochlear have?

As of the most recent reporting period, Cochlear reported total debt of A$154.47M.

How much cash does Cochlear have on hand?

Cochlear reported A$180.68M in cash and cash equivalents in its most recent financial results.

What is Cochlear’s dividend yield?

Cochlear currently has a dividend yield of 3.46%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.